These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8515561)
1. [Antimicrobial activities of aspoxicillin of fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Apr; 46(4):295-309. PubMed ID: 8515561 [TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898 [TBL] [Abstract][Full Text] [Related]
3. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001]. Abe T; Fukuoka T; Sato Y; Ito K; Sei M Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735 [TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical studies on aspoxicillin in the pediatric field]. Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M Jpn J Antibiot; 1985 Jul; 38(7):1868-81. PubMed ID: 3851860 [TBL] [Abstract][Full Text] [Related]
6. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related]
7. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012). Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304 [TBL] [Abstract][Full Text] [Related]
8. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000]. Nakasone I; Onaga S; Fukunaga H; Saitoh H; Yamane N; Sato Y Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533 [TBL] [Abstract][Full Text] [Related]
10. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group]. Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H; Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates]. Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192 [TBL] [Abstract][Full Text] [Related]
12. [The antimicrobial activity of cefteram against recently clinically detected and isolated strains]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K Jpn J Antibiot; 1993 Sep; 46(9):801-17. PubMed ID: 8254900 [TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activities of ceftriaxone against clinically isolated strains]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Jul; 45(7):774-98. PubMed ID: 1522669 [TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients]. Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076 [TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856 [TBL] [Abstract][Full Text] [Related]
17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)]. Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)]. Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284 [TBL] [Abstract][Full Text] [Related]
19. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011. Flamm RK; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578 [TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity of oral Cephems against various clinically isolated strains]. Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]